(Q40418835)

English

Value of 111In-DOTA-lanreotide and 111In-DOTA-DPhe1-Tyr3-octreotide in differentiated thyroid cancer: results of in vitro binding studies and in vivo comparison with 18F-FDG PET.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Value of 111In-DOTA-lanreotide and 111In-DOTA-DPhe1-Tyr3-octreotide in differentiated thyroid cancer: results of in vitro binding studies and in vivo comparison with 18F-FDG PET. (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

differentiated thyroid carcinoma

1 reference

based on heuristic

inferred from title

author name string

Margarida Rodrigues

1

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Tatjana Traub-Weidinger

2

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Maria Leimer

3

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Shuren Li

4

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Fritz Andreae

5

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Peter Angelberger

6

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Robert Dudczak

7

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Irene Virgolini

8

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

publication date

21 May 2005

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

European Journal of Nuclear Medicine and Molecular Imaging

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

32

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

1144-1151

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

https://scigraph.springernature.com/pub.10.1007/s00259-005-1820-1

0 references

DOTA-lanreotide: a novel somatostatin analog for tumor diagnosis and therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/15909194

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

131I treatment of 131I negative whole body scan, and positive thyroglobulin in differentiated thyroid carcinoma: what is being treated?

1 reference

https://pubmed.ncbi.nlm.nih.gov/15909194

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

DOTATOC: a powerful new tool for receptor-mediated radionuclide therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/15909194

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preoperative diagnostic value of [(18)F] fluorodeoxyglucose positron emission tomography in patients with radioiodine-negative recurrent well-differentiated thyroid carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/15909194

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/15909194

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Somatostatin receptor subtype expression in human thyroid and thyroid carcinoma cell lines

1 reference

https://pubmed.ncbi.nlm.nih.gov/15909194

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cross-competition between vasoactive intestinal peptide and somatostatin for binding to tumor cell membrane receptors

1 reference

https://pubmed.ncbi.nlm.nih.gov/15909194

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biokinetics and dosimetry in patients administered with (111)In-DOTA-Tyr(3)-octreotide: implications for internal radiotherapy with (90)Y-DOTATOC

1 reference

https://pubmed.ncbi.nlm.nih.gov/15909194

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

18F-FDG-PET in the follow-up of thyroid cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15909194

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15909194

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Compare FDG-PET and Tc-99m tetrofosmin SPECT to detect metastatic thyroid carcinoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15909194

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995 [see commetns]

1 reference

https://pubmed.ncbi.nlm.nih.gov/15909194

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In-111 DTPA-octreotide scintigraphy for disease detection in metastatic thyroid cancer: comparison with F-18 FDG positron emission tomography and extensive conventional radiographic imaging

1 reference

https://pubmed.ncbi.nlm.nih.gov/15909194

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of indium-111 pentetreotide somatostatin receptor scintigraphy to detect recurrent thyroid carcinoma in patients without detectable iodine uptake

1 reference

https://pubmed.ncbi.nlm.nih.gov/15909194

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment guidelines for patients with thyroid nodules and well-differentiated thyroid cancer. American Thyroid Association

1 reference

https://pubmed.ncbi.nlm.nih.gov/15909194

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thyroglobulin and low-dose iodine-131 and technetium-99m-tetrofosmin whole-body scintigraphy in differentiated thyroid carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/15909194

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative somatostatin receptor scintigraphy using in-111-DOTA-lanreotide and in-111-DOTA-Tyr3-octreotide versus F-18-FDG-PET for evaluation of somatostatin receptor-mediated radionuclide therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/15909194

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiotherapy with a radiolabeled somatostatin analogue, [111In-DTPA-D-Phe1]-octreotide. A case history

1 reference

https://pubmed.ncbi.nlm.nih.gov/15909194

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pulmonary metastasis of differentiated thyroid carcinoma: treatment results in 101 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/15909194

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[131I-accumulating pulmonary and bone metastases of differentiated thyroid cancer with low serum thyroglobulin levels--an exception in tumor follow-up?]

1 reference

https://pubmed.ncbi.nlm.nih.gov/15909194

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Is [18F]-2-fluoro-2-deoxy-d-glucose (FDG) scintigraphy with non-dedicated positron emission tomography useful in the diagnostic management of suspected metastatic thyroid carcinoma in patients with no detectable radioiodine uptake?

1 reference

https://pubmed.ncbi.nlm.nih.gov/15909194

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fluorine-18-FDG and iodine-131-iodide uptake in thyroid cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15909194

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radionuclide-labeled somatostatin analogues for diagnostic and therapeutic purposes in nonmedullary thyroid cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15909194

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro and in vivo studies of three radiolabelled somatostatin analogues:123I-Octreotide (OCT),123I-Tyr-3-OCT and111In-TIRA-d-Phe-1-OCT

1 reference

https://pubmed.ncbi.nlm.nih.gov/15909194

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Indium-111-DOTA-lanreotide: biodistribution, safety and radiation absorbed dose in tumor patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/15909194

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use

1 reference

https://pubmed.ncbi.nlm.nih.gov/15909194

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In- and Y-DOTA-lanreotide: results and implications of the MAURITIUS trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/15909194

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low-energy electron emitters for targeted radiotherapy of small tumours.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15909194

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

1 reference

https://pubmed.ncbi.nlm.nih.gov/15909194

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Receptor-mediated radiotherapy with 90Y-DOTA-D-Phe1-Tyr3-octreotide

1 reference

https://pubmed.ncbi.nlm.nih.gov/15909194

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of 99Tcm-tetrofosmin with 201Tl and 131I in the detection of differentiated thyroid cancer metastases

1 reference

https://pubmed.ncbi.nlm.nih.gov/15909194

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Octreotide scintigraphy in patients with differentiated thyroid carcinoma: contribution for patients with negative radioiodine scan

1 reference

https://pubmed.ncbi.nlm.nih.gov/15909194

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Somatostatin receptor subtypes, octreotide scintigraphy, and clinical response to octreotide treatment in patients with neuroendocrine tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/15909194

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Can iodine-131 whole-body scan be replaced by thyroglobulin measurement in the post-surgical follow-up of differentiated thyroid carcinoma?

1 reference

https://pubmed.ncbi.nlm.nih.gov/15909194

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

PET in the follow-up of differentiated thyroid cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15909194

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fluorine-18 fluorodeoxyglucose positron emission tomography in thyroid cancer: results of a multicentre study

1 reference

https://pubmed.ncbi.nlm.nih.gov/15909194

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00259-005-1820-1

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40418835&oldid=1507634902"